Bacterial exotoxins downregulate cathelicidin (hCAP-18/LL-37) and human beta-defensin 1 (HBD-1) expression in the intestinal epithelial cells.

Cellular Microbiology
Krishnendu ChakrabortySantasabuj Das

Abstract

Cathelicidin (hCAP-18/LL-37) and beta-defensin 1 (HBD-1) are human antimicrobial peptides (AMPs) with high basal expression levels, which form the first line of host defence against infections over the epithelial surfaces. The antimicrobial functions owe to their direct microbicidal effects as well as the immunomodulatory role. Pathogenic microorganisms have developed multiple modalities including transcriptional repression to combat this arm of the host immune response. The precise mechanisms and the pathogen-derived molecules responsible for transcriptional downregulation remain unknown. Here, we have shown that enteric pathogens suppress LL-37 and HBD-1 expression in the intestinal epithelial cells (IECs) with Vibrio cholerae and enterotoxigenic Escherichia coli (ETEC) exerting the most dramatic effects. Cholera toxin (CT) and labile toxin (LT), the major virulence proteins of V. cholerae and ETEC, respectively, are predominantly responsible for these effects, both in vitro and in vivo. CT transcriptionally downregulates the AMPs by activating several intracellular signalling pathways involving protein kinase A (PKA), ERK MAPKinase and Cox-2 downstream of cAMP accumulation and inducible cAMP early repressor (ICER) may mediat...Continue Reading

References

Apr 1, 1992·Current Opinion in Genetics & Development·P K Brindle, M R Montminy
Feb 1, 1995·Molecular Microbiology·K M Ottemann, J J Mekalanos
Jan 1, 1995·Annual Review of Cell and Developmental Biology·P Sassone-Corsi
May 16, 1998·The Biochemical Journal·S Ogbourne, T M Antalis
May 23, 1998·The International Journal of Biochemistry & Cell Biology·P Sassone-Corsi
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·R BalsJ M Wilson
Apr 11, 2000·Emerging Infectious Diseases·A BasuG B Nair
Apr 6, 2002·American Journal of Respiratory and Critical Care Medicine·Susanne Schaller-BalsRobert Bals
May 16, 2002·Infection and Immunity·Gillian MorrisonJulia Dorin
May 16, 2002·Infection and Immunity·Christian MoserJames M Wilson
Jun 21, 2002·Trends in Cell Biology·Philip J S Stork, John M Schmitt
Mar 11, 2003·Acta Oto-laryngologica·Seon Tae KimHeung-Man Lee
Jun 6, 2003·Cellular and Molecular Life Sciences : CMLS·R Bals, J M Wilson
Jun 6, 2003·Cellular and Molecular Life Sciences : CMLS·K Gaston, P S Jayaraman
Oct 1, 1953·The Journal of Pathology and Bacteriology·S N DE, D N CHATTERJE
Jan 27, 2004·Antimicrobial Agents and Chemotherapy·Gururaja Perumal PazhaniS K Niyogi
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Carrie M RosenbergerB Brett Finlay
Apr 23, 2004·Infection and Immunity·Tarek K ZaaloukVincent McDonald
May 13, 2004·Clinical and Diagnostic Laboratory Immunology·David B HuangPablo C Okhuysen
Jul 21, 2004·Molecular Immunology·Jürgen SchauberWolfgang Scheppach
Aug 12, 2004·The Journal of Investigative Dermatology·Jürgen HarderJens-Michael Schröder
Dec 1, 2004·Journal of Leukocyte Biology·Dawn M E BowdishRobert E W Hancock
Apr 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ole E SørensenTomas Ganz
Apr 15, 2005·Molecular Immunology·Rachel DommettMona Bajaj-Elliott
May 24, 2005·Nature Immunology·Michael E Selsted, Andre J Ouellette
Jun 15, 2005·Cellular Microbiology·Peter BergmanBirgitta Agerberth
Jun 25, 2005·Chemical Immunology and Allergy·Christoph Beisswenger, Robert Bals
Jul 19, 2005·Molecular Immunology·Atabak R RoyaeeDavid C H Yang
Sep 28, 2005·The Journal of Investigative Dermatology·Michael D HowellDonald Y M Leung
Jun 3, 2006·Proceedings of the National Academy of Sciences of the United States of America·Rubhana RaqibBirgitta Agerberth
Jun 6, 2006·Gene·Simanti DattaDonald L Court

❮ Previous
Next ❯

Citations

Jan 6, 2010·Archivum Immunologiae Et Therapiae Experimentalis·Robert BuckiWojciech Sokołowski
Sep 10, 2009·Infection and Immunity·Gregory M GlennE Michael Danielsen
Nov 17, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·Sergio CrovellaPaolo Gasparini
Jun 1, 2010·Toxins·Benjamin Mudrak, Meta J Kuehn
Mar 4, 2014·Pharmaceuticals·Guolong Zhang, Lakshmi T Sunkara
Jul 18, 2015·Pharmaceuticals·Biljana Mojsoska, Håvard Jenssen
Mar 3, 2010·International Journal of Immunogenetics·L SegatS Crovella
Nov 12, 2015·Biochimica Et Biophysica Acta·Daniela XhindoliAlessandro Tossi
Dec 24, 2014·International Journal of Antimicrobial Agents·Gabriela M WassingAnne M van der Does
Oct 22, 2013·Molecular Immunology·Lakshmi T SunkaraGuolong Zhang
May 25, 2010·Biochemical and Biophysical Research Communications·Gudmundur Hrafn GudmundssonBirgitta Agerberth
Nov 20, 2012·Innate Immunity·Ernesto Prado Montes de Oca
Oct 6, 2015·BioFactors·Katarzyna BandurskaPiotr Krupa
May 3, 2016·Inflammatory Bowel Diseases·Lihua SunHua Yang
Oct 8, 2009·Journal of Leukocyte Biology·Mona DossKevan L Hartshorn
Nov 18, 2014·Immunity, Inflammation and Disease·José Carlos SantosRui Appelberg
Aug 8, 2018·Human Vaccines & Immunotherapeutics·Ephrem Debebe ZegeyePål Puntervoll
Sep 6, 2013·Microbiology and Molecular Biology Reviews : MMBR·Vanessa Liévin-Le Moal, Alain L Servin
Oct 5, 2013·Clinical Microbiology Reviews·Matthew A CroxenB Brett Finlay
Dec 8, 2009·Nature Reviews. Microbiology·Matthew A Croxen, B Brett Finlay
Oct 9, 2009·Autoimmunity·R L GuimarãesS Crovella
Feb 22, 2012·FEMS Microbiology Letters·Samantha Gruenheid, Hervé Le Moual
Mar 3, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Piyush BaindaraSanti M Mandal
Feb 7, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Min WanJesper Z Haeggström
Aug 19, 2011·The FEBS Journal·Andreas CederlundBirgitta Agerberth
Jun 16, 2012·Journal of Leukocyte Biology·Anne M van der DoesLennart Lindbom
Aug 2, 2020·The Journal of Pharmacy and Pharmacology·Francisca B M SousaJand V R Medeiros
Apr 28, 2016·Pharmacological Reports : PR·Adam FabisiakJakub Fichna

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.